PDS01ADC: clinical trials recruiting now

Phase breakdown

Conditions being studied

Recruiting trials involving PDS01ADC

• A Phase I/II Study of PDS01ADC With Docetaxel and Abiraterone in Adults With Metastatic Castration Sensitive and PDS01ADC With Docetaxel in Castration Resistant Prostate Cancer
  NCT04633252 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 110 Years · Sex: Male · 1 location
• A Phase II Study Evaluating T-Cell Clonality After Stereotactic Body Radiation Therapy Alone and in Combination With the Immunocytokine PDS01ADC in Localized High and Intermediate Risk Prostate Cancer Treated With Androgen Deprivation Therapy
  NCT05361798 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 1 location
• Enzalutamide and PDS01ADC in PET Positive Recurrent Prostate Cancer (pprPC) Without Testosterone Lowering Therapy
  NCT06096870 · Phase: Phase 2 · Ages: 18 Years to 120 Years · Sex: Male · 1 location
• PDS01ADC Monotherapy and in Combination With M7824 in Advanced Kaposi Sarcoma
  NCT04303117 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 99 Years · Sex: All (male and female) · 1 location
• PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma
  NCT05286814 · Phase: Phase 2 · Ages: 18 Years to 120 Years · Sex: All (male and female) · 1 location

Common questions

How many recruiting trials involve PDS01ADC?

5 recruiting trials across 15 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.